UK Life Sciences Company Directory

Rapid genomic diagnostic device for sepsis and bacterial infections

GenomeKey is a biotechnology company developing an in vitro diagnostic device that uses whole genome sequencing and machine learning to identify bacteria and their antimicrobial resistance profiles directly from patient blood within hours. The device targets sepsis, where current culture-based diagnostics take 24 to…

Secure genomic data vaults and permissioned research access

Genomes.io is a London genomics software company developing privacy-preserving storage and controlled access to individual whole-genome data. Its DNA Vault platform uses encrypted environments and permission-based access to genomic files. The company offers whole-genome sequencing through external laboratory providers…

DNA-based gene therapy platform for intercellular therapeutic gene delivery

Bitrobius Genetics is a UK biotech developing a novel DNA-based gene therapy platform technology designed to deliver functional copies of mutated genes to cells within a target tissue or organ. Its platform is based on the principle of DNA replication and intercellular transmission, aiming to achieve broad tissue…

Small molecule drug discovery targeting rare genetic diseases and oncology

Tay Therapeutics is a drug discovery company developing targeted small molecule therapies for rare genetic diseases and cancer. Its platform uses stop codon read-through technology to restore production of functional proteins disrupted by premature stop codon mutations, with programmes targeting oncology, cystic…

Custom peptide synthesis, antibodies, and protein analysis services

Alta Bioscience is a manufacturer and accredited analytical laboratory specialising in custom biochemical synthesis and protein analysis services. The company produces custom peptides, peptide libraries, DNA oligonucleotides, and polyclonal and monoclonal antibodies for academic, pharmaceutical, and food industry…

Immunotherapies targeting blood cancer precursor conditions before onset

Athernal Bio is a Cambridge-based biotechnology company developing targeted immunotherapies for high-risk clonal haematopoiesis, a widespread blood stem cell mutation condition that significantly increases the risk of acute myeloid leukaemia and other haematological cancers. The company's pipeline comprises three…

Integrated drug discovery, development and GMP manufacturing CRO

Concept Life Sciences is a contract research organisation delivering integrated drug discovery, development and GMP manufacturing services across facilities in Chapel-en-le-Frith, Edinburgh, Dundee and Sandwich. Its capabilities span medicinal chemistry, translational biology, ADME/DMPK, toxicology and GxP-compliant…

End-to-end production systems for cultivated meat

Cellcraft is a biotechnology company developing integrated systems for cultivated meat production. The company supplies the hardware, software, and biological inputs required to grow animal cells outside the body at commercial scale, targeting food producers and manufacturers seeking slaughter-free protein production.…

Causal cellular data and AI models for drug discovery

CellCodex is a biotechnology company that generates causal data from human cells to train predictive models for drug discovery. It programmes stem cells into pure, aged, disease-relevant cell types, perturbs them at genome scale with CRISPR and compounds, and reads the outcome in single cells. The company applies the…

Macrophage-based reprogramming of the innate immune system

Ojas Immune develops therapies that reprogramme macrophages, innate immune cells involved in inflammation, tissue repair and disease. Its platforms combine synthetic biology, stem cell engineering and computational modelling. SyntheMacs focuses on engineered macrophage cell therapies, while ReProMacs explores…

Lab operations and procurement platform for life science organisations

MyAmici s is a UK-based provider of laboratory operations software and managed procurement services for biotech and life science organisations. Its platform consolidates purchasing, inventory management, equipment tracking, and compliance functions into a single system, supported by a team of in-house procurement…

Clinical-stage anti-infectives targeting antimicrobial resistance and infectious disease

NovaBiotics is a clinical-stage biotechnology company developing first-in-class anti-infective therapies for difficult-to-treat infectious diseases, with a focus on antimicrobial resistance. Its pipeline is built on two proprietary platforms: an anti-infective peptide platform yielding antifungal and antibacterial…

AI platform engineering molecular glue drugs for undruggable targets

Ternary Therapeutics is a preclinical-stage biotechnology company developing an AI-driven platform for the rational design of molecular glue therapeutics. Molecular glues are small molecules that induce proximity between two proteins, enabling targeted degradation or modulation of disease-driving targets that lack…

Cell culture media, reagents, and instruments for life sciences

STEMCELL Technologies UK is the British subsidiary of STEMCELL Technologies Canada Inc., a privately held Canadian biotechnology company founded in 1993. The Cambridge facility serves as the company's European hub for sales, marketing, research and development, and customer training, supporting researchers across the…

Small-molecule HO-1 inhibitors to overcome chemotherapy resistance in tumours

Aethox Therapeutics is a preclinical biotechnology company developing small-molecule drugs that help solid tumours respond to chemotherapy and other standard cancer treatments. Its lead approach targets heme oxygenase-1 (HO-1), an enzyme produced by tumour-associated macrophages that can block cancer-fighting T cells…

National innovation centre accelerating drug discovery

Medicines Discovery Catapult (MDC) is an independent, not-for-profit national innovation centre that supports UK medicines discovery organisations across the full drug discovery pipeline. MDC provides access to specialist laboratory technologies, computational and AI-driven tools, translational R&D expertise, and…

Academic-industry translational research institute

The Milner Therapeutics Institute is a University of Cambridge biomedical research institute established to bridge academic science and pharmaceutical drug discovery. Founded in 2015 and based at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus, it operates both an in-house research programme and…

Generative AI platform for TCR therapy design and immune repertoire analysis

Synteny Biotechnology is a biotechnology company developing a platform that combines high-throughput TCR-antigen data generation with generative AI to design precision T cell receptor therapies for cancer. The platform addresses a critical bottleneck in the field, namely the scarcity of paired TCR-epitope interaction…

Synthetic chromosome engineering for crop plants

Syntato is a plant biotechnology company applying synthetic biology to design and build plant chromosomes. The company aims to make chromosomes modular and reusable so that adaptive traits can be added as single units while the native genome is preserved. It combines synthetic biology, automation and protein design,…

Engineered biochar for anaerobic digestion and wastewater treatment

Carbogenics is an industrial biotechnology company developing engineered biochar from difficult-to-recycle organic and paper waste. Its CreChar material supports microbial activity and improves process stability in anaerobic digesters, while FilaChar is being developed for pollutant removal and improved wastewater…